Accueil / Tag Archives: Product/Service

Tag Archives: Product/Service

Cystic Fibrosis Foundation Statement on FDA Approval of TRIKAFTA, the First Triple-Combination Therapy for the Most Common CF Mutation

Monday, October 21st 2019 at 10:01pm UTC BETHESDA, Md.–(BUSINESS WIRE)– Today’s FDA approval of TRIKAFTA (elexacaftor/ivacaftor/tezacaftor), the highly effective and highly anticipated triple-combination CFTR modulator, marks the start of a new era in cystic fibrosis. This medicine represents the single greatest therapeutic advancement in the history of CF, offering a …

Plus »

Retrospective Real-World Comparative Analysis Highlights Safety of Vedolizumab and Anti-TNF? Therapies in Biologic-Naïve Patients with Ulcerative Colitis or Crohn’s Disease

Monday, October 21st 2019 at 5:00am UTC – Latest real-world data presented at UEG Week 2019 complements the extensive body of clinical evidence for the gut-selective biologic vedolizumab in biologic-naïve patients with moderately to severely active ulcerative colitis or Crohn’s disease   OSAKA, Japan–(BUSINESS WIRE)– Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) …

Plus »

Takeda obtient une licence pour le traitement de la maladie cœliaque de première classe de COUR Pharmaceuticals à la suite d’une étude de validation de principe positive de phase 2a

Tuesday, October 22nd 2019 at 6:15pm UTC ? Les données les plus récentes d’une étude de phase 2a présentée lors de la UEG Week 2019, à Barcelone, en Espagne, soulignent le potentiel de la médecine expérimentale pour prévenir l’activation immunitaire induite par le gluten chez les patients atteints de la …

Plus »

Tiaki Therapeutics Presents Data on Identification of a Novel Target for Neuroinflammatory-driven Neurodegenerative Disease Validated by Its Systems Biology Platform

Monday, October 21st 2019 at 4:00pm UTC Proprietary platform recapitulates neuroinflammatory signature from Alzheimer’s Disease patients Data presented at Society for Neuroscience 49th Annual Meeting CAMBRIDGE, Mass.–(BUSINESS WIRE)– Tiaki Therapeutics, a company developing treatments for patients suffering from age-related dementias by targeting the neuroinflammation that drives cognitive decline, announced today …

Plus »

SkyKnight Capital Invests in Home Healthcare Leader AeroCare

Monday, October 21st 2019 at 12:00pm UTC SAN FRANCISCO–(BUSINESS WIRE)– SkyKnight Capital (“SkyKnight”), a San Francisco based private equity firm, announced that it has made an investment into AeroCare Holdings, Inc. (“AeroCare” or the “Company”), a leading provider of home healthcare solutions focused on patients with chronic respiratory conditions. AeroCare …

Plus »

 Vertex Announces Reimbursement of Cystic Fibrosis Medicines SYMDEKO® (tezacaftor/ivacaftor and ivacaftor) for Eligible Patients Ages 12 and Older, and ORKAMBI® (lumacaftor/ivacaftor) in Children Ages 2 to 5, With Certain CFTR Mutations in Australia

Saturday, October 19th 2019 at 11:29pm UTC LONDON–(BUSINESS WIRE)– Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) today announced that SYMDEKO® (tezacaftor/ivacaftor and ivacaftor) is reimbursed in Australia for people with cystic fibrosis (CF) ages 12 years and older who are homozygous for the F508del mutation or who have one copy of the …

Plus »

Takeda adquiere la licencia de la innovadora terapia para la enfermedad celíaca de COUR Pharmaceuticals después de un estudio positivo de fase 2a de prueba de concepto

Tuesday, October 22nd 2019 at 1:29pm UTC ? Datos de última hora de un estudio de fase 2a presentados en la UEG Week 2019, Barcelona, España, destacan el potencial de un fármaco en investigación para prevenir la activación inmunitaria inducida por el gluten en pacientes con enfermedad celíaca ? Takeda …

Plus »

Moderna Receives FDA Fast Track Designation for Propionic Acidemia Program (mRNA-3927)

Tuesday, October 22nd 2019 at 8:15pm UTC mRNA-3927 is Moderna’s second rare disease program to receive Fast Track designation mRNA-3927 uses the same proprietary LNP formulation as mRNA-1944 (antibody against Chikungunya virus) and mRNA-3704 (methylmalonic acidemia) CAMBRIDGE, Mass.–(BUSINESS WIRE)– Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger …

Plus »

Sonnet BioTherapeutics Selects Abzena as Clinical Stage Manufacturing Partner for its IL-12-FHAB cytokine-derived Therapeutic Candidate

Tuesday, October 22nd 2019 at 1:28pm UTC PRINCETON, N.J. & SAN DIEGO–(BUSINESS WIRE)– Sonnet BioTherapeutics Inc., a clinical stage biopharmaceutical developing innovative targeted biologic drugs, announced today that it has selected Abzena as its manufacturing partner for SON-1010, an IL-12-FHAB cytokine, in preparation for clinical development. SON-1010 uses Sonnet’s proprietary …

Plus »

Disarm Therapeutics Reports Preclinical Data Demonstrating Small Molecule SARM1 Inhibitors Preserve Both Axonal Structure and Function In Vitro and In Vivo

Tuesday, October 22nd 2019 at 4:00pm UTC Presentation at Neuroscience 2019 shows that Disarm’s novel small molecule SARM1 inhibitors reproduce the axonal protection phenotype seen with SARM1 genetic deletion CAMBRIDGE, Mass.–(BUSINESS WIRE)– Disarm Therapeutics, a biotechnology company creating a new class of disease-modifying therapeutics for patients with axonal degeneration, today …

Plus »
>
Macbook Pro
* Intel Core i7 (3.8GHz, 6MB cache)
* Retina Display (2880 x 1880 px)
* NVIDIA GeForce GT 750M (Iris)
* 802.11ac Wi-Fi and Bluetooth 4.0
* Thunderbolt 2 (up to 20Gb/s)
* Faster All-Flash Storage (X1)
* Long Lasting Battery (9 hours)
BIENVENUE CHEZ BIOTECH FINANCES
Vous appréciez nos informations ?
Recevez nos alertes, nos dernières actualités, suivez-nous, enregistrez-vous gratuitement, rejoignez notre communauté. Merci à vous !
ARE YOU READY? GET IT NOW!
Increase more than 500% of Email Subscribers!
Your Information will never be shared with any third party.
DÉCOUVREZ LA SOLUTION STRATA !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHBzOi8vd3d3LmJpb3RlY2gtZmluYW5jZXMuY29tL3dwLWNvbnRlbnQvdXBsb2Fkcy8yMDE1LzA3L1NhdHJhLTIubXA0IiBmcmFtZWJvcmRlcj0iMCIgYWxsb3dmdWxsc2NyZWVuPjwvaWZyYW1lPg==
Retrouvez nous sur http://stratahealth.com/fr/
Un ensemble de solutions performantes
pour assurer le continuum de vos données.
Biotech Finances
SUIVEZ-NOUS, ENREGISTREZ-VOUS !
PGlmcmFtZSB3aWR0aD0iMTAwJSIgaGVpZ2h0PSIxMDAlIiBzcmM9Imh0dHA6Ly93d3cueW91dHViZS5jb20vZW1iZWQvajhsU2NITzJtTTAiIGZyYW1lYm9yZGVyPSIwIiBhbGxvd2Z1bGxzY3JlZW4+PC9pZnJhbWU+
All rights reserved © Company Name, 2014
Concours Genopole Young Biotech Award
* 100 000 € pour la meilleure Biotech
* Réservé aux biotechs hors santé
* 6 mois d'hébergement gratuit
* Un accompagnement personnalisé
* Etude de marché offerte
* Expertise du projet par EY
* Et nombre d'autres avantages...
S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.

S'inscrire au 15H BIOTECH EXPRESS
Chaque jour à 15H recevez gratuitement les news des biotechs, des medtechs,et des fonds spécialisés. Levées ; partenariats ; nominations ; fusacq ; closing ; milestone...
2019 (C) All rights reserved.

En cochant cette case, j’accepte la Politique de confidentialité de ce site et de recevoir des informations de notre part.